Kurt A. Zimmerman

Kurt A. Zimmerman

Auto-generated profile, based on publicly available information

Kurt A. Zimmerman

Division of Nephrology, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Kidney360
Verified
Journal Article
Open access
BMBibi Maryam
Bibi Maryam
MSMorgan E. Smith
Morgan E. Smith
SMSarah J. Miller
Sarah J. Miller
HNHariharasudan Natarajan
Hariharasudan Natarajan
KZKurt A. Zimmerman
Kurt A. Zimmerman
AKI is characterized by a sudden, and usually reversible, decline in kidney function. In mice, ischemia–reperfusion injury (IRI) is commonly used to model the pathophysiologic features of clinical AKI. Macrophages are a unifying feature of IRI as they regulate both the initial injury response as well as the long-term outcome following resolution of injury. Initially, macrophages in the kidney take on a proinflammatory phenotype characterized by the production of inflammatory cytokines, such as CCL2 (monocyte chemoattractant protein 1), IL-6, IL-1β, and TNF-α. Release of these proinflammatory cytokines leads to tissue damage. After resolution of the initial injury, macrophages take on a reparative role, aiding in tissue repair and restoration of kidney function. By contrast, failure to resolve the initial injury results in prolonged inflammatory macrophage accumulation and increased kidney damage, fibrosis, and the eventual development of CKD. Despite the extensive amount of literature that has ascribed these functions to M1/M2 macrophages, a recent paradigm shift in the macrophage field now defines macrophages on the basis of their ontological origin, namely monocyte-derived and tissue-resident macrophages. In this review, we focus on macrophage phenotype and function during IRI-induced injury, repair, and transition to CKD using both the classic (M1/M2) and novel (ontological origin) definition of kidney macrophages.

1 April 2022 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
CSCheng J. Song
Cheng J. Song
ZLZhang Li
Zhang Li
UAUmmey Khalecha Bintha Ahmed
Ummey Khalecha Bintha Ahmed
SBSarah J. Bland
Sarah J. Bland
AYAlex Yashchenko
Alex Yashchenko
KZKurt A. Zimmerman
Kurt A. Zimmerman
Background: Inducible disruption of cilia-related genes in adult mice results in slowly progressive cystic disease, which can be greatly accelerated by renal injury. Methods: To identify in an unbiased manner modifier cells that may be influencing the differential rate of cyst growth in injured versus non-injured cilia mutant kidneys at a time of similar cyst severity, we generated a single-cell atlas of cystic kidney disease. We conducted RNA-seq on 79,355 cells from control mice and adult-induced conditional Ift88 mice (hereafter referred to as cilia mutant mice) that were harvested approximately 7 months post-induction or 8 weeks post 30-minute unilateral ischemia reperfusion injury. Results: Analyses of single-cell RNA-seq data of CD45+ immune cells revealed that adaptive immune cells differed more in cluster composition, cell proportion, and gene expression than cells of myeloid origin when comparing cystic models with one another and with non-cystic controls. Surprisingly, genetic deletion of adaptive immune cells significantly reduced injury-accelerated cystic disease but had no effect on cyst growth in non-injured cilia mutant mice, independent of the rate of cyst growth or underlying genetic mutation. Using NicheNet, we identified a list of candidate cell types and ligands that were enriched in injured cilia mutant mice compared with aged cilia mutant mice and non-cystic controls that may be responsible for the observed dependence on adaptive immune cells during injury-accelerated cystic disease. Conclusions: Collectively, these data highlight the diversity of immune cell involvement in cystic kidney disease.

15 May 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
AYAlex Yashchenko
Alex Yashchenko
SBSarah J. Bland
Sarah J. Bland
CSCheng J. Song
Cheng J. Song
UAUmmey Khalecha Bintha Ahmed
Ummey Khalecha Bintha Ahmed
RSRachel Sharp
Rachel Sharp
KZKurt A. Zimmerman
Kurt A. Zimmerman
Kidney macrophages are comprised of both monocyte-derived and tissue resident populations; however, the heterogeneity of kidney macrophages and factors that regulate their heterogeneity are poorly understood. Herein, we performed single cell RNA sequencing (scRNAseq), fate mapping, and parabiosis to define the cellular heterogeneity of kidney macrophages in healthy mice. Our data indicate that healthy mouse kidneys contain four major subsets of monocytes and two major subsets of kidney resident macrophages (KRM) including a population with enriched Ccr2 expression, suggesting monocyte origin. Surprisingly, fate mapping data using the newly developed Ms4a3Cre Rosa Stopf/f TdT model indicate that less than 50% of Ccr2+ KRM are derived from Ly6chi monocytes. Instead, we find that Ccr2 expression in KRM reflects their spatial distribution as this cell population is almost exclusively found in the kidney cortex. We also identified Cx3cr1 as a gene that governs cortex specific accumulation of Ccr2+ KRM and show that loss of Ccr2+ KRM reduces the severity of cystic kidney disease in a mouse model where cysts are mainly localized to the kidney cortex. Collectively, our data indicate that Cx3cr1 regulates KRM heterogeneity and niche-specific disease progression.

15 August 2025 in Circulation Research
Verified
Journal Article
Closed access
TVThamizhiniyan Venkatesan
Thamizhiniyan Venkatesan
MTMaria Toumpourleka
Maria Toumpourleka
MNMonika Niewiadomska
Monika Niewiadomska
KFKassem Farhat
Kassem Farhat
LMLynsie Morris
Lynsie Morris
SSStavros Stavrakis
Stavros Stavrakis
BACKGROUND: We previously showed in a rat model of heart failure with preserved ejection fraction (HFpEF) that transcutaneous vagus nerve stimulation (tVNS) reduced cardiac fibrosis and inflammation. However, macrophage-mediated mechanisms through which tVNS rescues cardiac function remain poorly understood. METHODS: We induced HFpEF in 8-week-old mice by a combination of a high-fat diet and l -NG-nitro arginine methyl ester for 5 weeks, followed by 4 weeks of tVNS or sham stimulation. At this time, we analyzed cardiac function by echocardiography and immune cell numbers by single-cell RNA sequencing and flow cytometry. RESULTS: Our data demonstrate that HFpEF mice exhibited diastolic dysfunction, left ventricular hypertrophy, and fibrosis, consistent with HFpEF, and that tVNS significantly improved HFpEF severity. Analysis of merged single-cell RNA sequencing data from control, HFpEF+sham, and HFpEF+tVNS mice showed that HFpEF was associated with the accumulation of Spp1 -expressing CCR2 (C-C chemokine receptor type 2) + cardiac resident macrophages (CRM). Furthermore, treatment with tVNS reduced the number of CCR2 + CRM and the expression of Spp1 while also inducing the expression of Igf1 in TLF + (Timd4 + [T-cell immunoglobulin and mucin domain containing 4 + ]/Lyve1 + [Lymphatic vessel endothelial hyaluronan receptor 1 + ]/Folr2 + [Folate receptor 2 + ]) and MHC2 + (Major histocompatibility complex 2 + ) CRM. Global deletion of Spp1 or blockade of CCR2 + CRM recruitment improved HFpEF, whereas TLF + /MHC2 + specific deletion of Igf1 reversed the protective effect of tVNS on HFpEF. The benefits of tVNS were also abolished in the setting of disrupted acetylcholine/α7nAChR (α7 nicotinic acetylcholine receptor) signaling, either via pharmacological inhibition of α7nAChR or choline acetyltransferase deletion in CD4 + (cluster of differentiation) T cells. CONCLUSIONS: Collectively, our data indicate that tVNS improves HFpEF by reducing Spp1 expressing CCR2 + CRM and inducing expression of proreparative Igf1 in TLF + /MHC2 + CRM. These effects are mediated through cholinergic signaling, highlighting a neuroimmune pathway in HFpEF.

28 June 2021 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
KZKurt A. Zimmerman
Kurt A. Zimmerman
ZYZhengqin Yang
Zhengqin Yang
JLJeremie Lever
Jeremie Lever
ZLZhang Li
Zhang Li
MCMandy J. Croyle
Mandy J. Croyle
JGJames F. George
James F. George
In this report, we performed parabiosis surgery on inbred Lewis rats and showed that rat kidney resident macrophages (KRMs), identified using our novel cross-species markers, are minimally dependent on peripheral blood input. Thus, for the first time, to our knowledge, we confirm that a hallmark of mouse KRMs is also present in KRMs isolated from another species.

24 June 2021 in Kidney360
Verified
Journal Article
Closed access
PDF file
EAErnald Jules G. Aloria
Ernald Jules G. Aloria
CSCheng J. Song
Cheng J. Song
ZLZhang Li
Zhang Li
MCMandy J. Croyle
Mandy J. Croyle
MMMichal Mrug
Michal Mrug
BYBradley K. Yoder
Bradley K. Yoder
Key Points: Ly6chi infiltrating macrophage numbers are increased in injured, conditional Ift88 mice, compared with controls. Loss of Ly6chi infiltrating macrophages slows injury-accelerated cystic disease. Ly6chi infiltrating macrophages drive cystic disease in non-Pkd1–deficient cystic models.